Rothschild Investment LLC’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$325K Buy
1,667
+1,462
+713% +$303K 0.01% 735
2026
Q1
$46K Buy
205
+35
+21% +$8.72K ﹤0.01% 1142
2025
Q4
$40.9K Buy
170
+7
+4% +$1.79K ﹤0.01% 1084
2025
Q3
$44.6K Buy
163
+3
+2% +$819 ﹤0.01% 1020
2025
Q2
$41.3K Sell
160
-10
-6% -$2.38K ﹤0.01% 827
2025
Q1
$38.1K Sell
170
-13
-7% -$3.04K ﹤0.01% 850
2024
Q4
$41.9K Sell
183
-53
-22% -$12.8K ﹤0.01% 822
2024
Q3
$57.6K Buy
236
+4
+2% +$894 ﹤0.01% 747
2024
Q2
$44.4K Buy
232
+100
+76% +$20.3K ﹤0.01% 773
2024
Q1
$26.1K Buy
132
+17
+15% +$3.12K ﹤0.01% 870
2023
Q4
$19.8K Buy
+115
New +$17.7K ﹤0.01% 869

Other funds holding RMD

Rothschild Investment LLC's RMD Position: Q2 2026 in Review

Rothschild Investment LLC increased its ResMed (RMD) stake by 713% in Q2 2026, buying an estimated $303K and bringing the position to 1,667 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #735.

Rothschild Investment LLC first reported a position in RMD in Q4 2023 and has held it in 11 quarters since. 707 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Rothschild Investment LLC held 1,667 shares of ResMed worth $325K as of Q2 2026.
  • Rothschild Investment LLC bought 1,462 ResMed shares in Q2 2026, an estimated $303K.
  • ResMed made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #735 holding.
  • Rothschild Investment LLC first reported a position in ResMed in Q4 2023 and has held it in 11 quarters since.
  • 707 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.